Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
January 10, 2020 Off

Top 5 Generic Opportunities in Pharmaceuticals to Watch in 2019: Perspective for the Future – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Top 5 Generic Opportunities in Pharmaceuticals to Watch in 2019: Perspective for the Future” report has been added…

January 10, 2020 Off

Kramer Levin Launches Biologics Law Blog

By BusinessWire

NEW YORK–(BUSINESS WIRE)–Kramer Levin Naftalis & Frankel LLP today launched the Bio Law Blog, which provides insights into intellectual property…

January 10, 2020 Off

Adimab Provides Year-End Update on 2019 Partnership Activities

By BusinessWire

– 20 Partnerships Added – – 62 Milestones Achieved – – More than 315 Total Therapeutic Programs at Year-End 2019…

January 10, 2020 Off

Applied DNA to Hold Investment Community Meetings During the JP Morgan 38th Annual Healthcare Conference and Present at the Biotech Showcase 2020

By BusinessWire

STONY BROOK, N.Y.–(BUSINESS WIRE)–Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction…

January 10, 2020 Off

CEL-SCI to Participate in Upcoming Investor Conferences

By BusinessWire

VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM) announced today its Chief Executive Officer Geert Kersten will attend two upcoming healthcare…

January 10, 2020 Off

ANP Technologies, in Partnership with Fulgent Pharma, Teams with Moffitt Cancer Center to Develop a New Class of Leukemia Therapies

By BusinessWire

NEWARK, Del.–(BUSINESS WIRE)–ANP Technologies Inc. (ANP) and Fulgent Pharma LLC through their partner Moffitt Cancer Center have successfully licensed the…

January 10, 2020 Off

Bio-Thera Solutions Launches First Commercial Product, QLETLI® (格乐立®), in China

By BusinessWire

First Humira® Biosimilar to Launch in China GUANGZHOU, China–(BUSINESS WIRE)–#arthritis–Bio-Thera Solutions, Ltd., a fully-integrated pharmaceutical company, today announced that QLETLI®…

January 10, 2020 Off

Revance Announces Transformative Aesthetics Portfolio Transaction with Exclusive U.S. Distribution Agreement of FDA-Approved Dermal Fillers from TEOXANE SA

By BusinessWire

– TEOXANE SA RHA® portfolio: first and only range of FDA-approved dermal fillers for correction of dynamic wrinkles – –…

January 10, 2020 Off

Bayer and Azitra Partner to Harness the Human Skin Microbiome as a Source for New Natural Skin Care Products for Sensitive and Eczema-Prone Skin

By BusinessWire

Skin microbiome plays a crucial role in maintaining and restoring healthy human skin Azitra targets skin “friendly” bacteria to solve…

January 10, 2020 Off

Meissa Vaccines Receives U.S. FDA Fast Track Designation for Respiratory Syncytial Virus Vaccine, MV-012-968

By BusinessWire

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–#RSV—Meissa Vaccines (“Meissa”), a biotechnology company developing vaccines to prevent viral respiratory infections, announced today that…

Posts pagination

Previous 1 … 5,207 5,208 5,209 … 6,212 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector

December 18, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine